Evidence map›Paper›PMID 27296163›Full record

ArticleThe Laryngoscope2016

Idiopathic subglottic stenosis is associated with activation of the inflammatory IL-17A/IL-23 axis.

Alexander Gelbard, Nicolas-George Katsantonis, Masanobu Mizuta, Dawn Newcomb, Joseph Rotsinger, Bernard Rousseau, James J Daniero, Eric S Edell, Dale C Ekbom, Jan L Kasperbauer and 12 more

Open access · greenAbstract read
In one paragraph

Article in The Laryngoscope, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Whole genome sequencing reveals a specific microbiota in subglottic stenosis C. acnes may contribute to inflammation.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. PD-L1 Acts Independently of PD-1 as a Marker of Pathologic Fibroblasts in Laryngotracheal Stenosis.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2025
    Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 1 country.

Alexander GelbardDepartment of Otolaryngology, Vanderbilt University, Nashville, Tennessee. alexander.gelbard@vanderbilt.edu.
Nicolas-George KatsantonisDepartment of Otolaryngology, Vanderbilt University, Nashville, Tennessee.
Masanobu MizutaDepartment of Otolaryngology, Vanderbilt University, Nashville, Tennessee.
Dawn NewcombDepartment of Medicine, Division of Pulmonary and Critical Care, Vanderbilt University, Nashville, Tennessee.
Joseph RotsingerDepartment of Medicine, Division of Infectious Disease, Vanderbilt University, Nashville, Tennessee.
Bernard RousseauDepartment of Otolaryngology, Vanderbilt University, Nashville, Tennessee.
James J DanieroDepartment of Otolaryngology, University of Virginia Health System, Charlottesville, Virginia.
Eric S EdellDepartment of Medicine, Division of Pulmonary & Critical Care, Mayo Clinic, Rochester, Minnesota.
Dale C EkbomDepartment of Otolaryngology, Mayo Clinic, Rochester, Minnesota.
Jan L KasperbauerDepartment of Otolaryngology, Mayo Clinic, Rochester, Minnesota.
Alexander T HillelDepartment of Otolaryngology, Johns Hopkins, Baltimore, Maryland.
Liying YangDepartment of Medicine, New York University School of Medicine, New York, New York, U.S.A.
C Gaelyn GarrettDepartment of Otolaryngology, Vanderbilt University, Nashville, Tennessee.
James L NettervilleDepartment of Otolaryngology, Vanderbilt University, Nashville, Tennessee.
Christopher T WoottenDepartment of Otolaryngology, Vanderbilt University, Nashville, Tennessee.
David O FrancisDepartment of Otolaryngology, Vanderbilt University, Nashville, Tennessee.
Charles StrattonDepartment of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee.
Kevin JenkinsDepartment of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee.
Tracy L McGregorDepartment of Pediatrics, Division of Medical Genetics, Vanderbilt University, Nashville, Tennessee.
Jennifer A GaddyDepartment of Medicine, Division of Infectious Disease, Vanderbilt University, Nashville, Tennessee.
Timothy S BlackwellDepartment of Medicine, Division of Pulmonary and Critical Care, Vanderbilt University, Nashville, Tennessee.
Wonder P DrakeDepartment of Medicine, Division of Infectious Disease, Vanderbilt University, Nashville, Tennessee.
Vanderbilt University · USMayo Clinic · USJohns Hopkins University · USMayo Clinic in Arizona · USNew York University · USUniversity of Virginia Health System · USVA Tennessee Valley Healthcare System · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STACIE B DUSETZINA · 1995 to 2026
$172.8M
Mentoring in Translational Research in Interstitial Lung DiseasesK24HL127301 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Wonder P. Drake · 2016 to 2026
$1.2M
Immune Cell Modulation in Laryngotrachael FibrosisK23DC014082 · NIDCD · JOHNS HOPKINS UNIVERSITY · PI HILLEL, ALEXANDER · 2015 to 2019
$1.2M
Developing an Outcome Measuring Unilateral Vocal Fold Paralysis DisabilityK23DC013559 · NIDCD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FRANCIS, DAVID O. · 2014 to 2018
$990k
NCI NIH HHS P30 CA068485NHLBI NIH HHS K24 HL127301NIDCD NIH HHS K23 DC013559NIDCD NIH HHS K23 DC014082
6 · The paper itself

Abstract

objectives/hypothesisIdiopathic subglottic stenosis (iSGS) is a rare and devastating extrathoracic obstruction involving the lower laryngeal and upper tracheal airway. It arises without known antecedent injury or associated disease process. Persistent mucosal inflammation and a localized fibrotic response are hallmarks of the disease. Despite the initial clinical description of iSGS more than 40 year ago, there have been no substantive investigations into the pathogenesis of this enigmatic and progressive airway obstruction. In these studies, we present the initial characterization of the molecular pathogenesis underlying the fibrosing phenotype of iSGS.

methodsUtilizing 20 human iSGS and healthy control specimens, we applied histologic, immunohistochemical, molecular, and immunologic techniques.

resultsWe demonstrate significant activation of the canonical IL-23/IL-17A pathway in the tracheal mucosa of iSGS patients, as well as identify γδ T cells as the primary cellular source of IL-17A.

conclusionOur results suggest that aberrant mucosal immune activation is a component in of the pathogenesis of iSGS. Most critically, our work offers new targets for future therapeutic intervention. LEVEL OF EVIDENCE: NA Laryngoscope, 126:E356-E361, 2016.

Indexed as

Airway ObstructionCase-Control StudiesHumansInflammation MediatorsInterleukin-17Interleukin-23LarynxSignal TransductionTracheaTracheal StenosisIL17A protein, humanInflammation MediatorsInterleukin-17Interleukin-23idiopathic subglottis stenosisIL-17IL-17AiSGSISSlaryngotracheal stenosistracheal stenosis

Identifiers

PMID27296163
PMCPMC5077677
OpenAlexW2428301625

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.